Anti-Siglec-2/CD22 Antibody (Inotuzumab-CLM)
Catalog No.
F1854
Anti-Siglec-2/CD22 Antibody (Inotuzumab-CLM)
Featured Products
Inotuzumab-CLM is a CHO-expressed humanized antibody targeting Siglec-2/CD22.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
146.48 kDa
Dry ice
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
inotuzumab-CLM
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P20273
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Daudi Cell Line were stained with Anti-Siglec-2 / CD22 Reference Antibody (inotuzumab) and negative control protein respectively, washed and then followed by PE and analyzed with FACS, The EC50 is 0.06 ug/mL.
Siglec-2 / CD22
Please avoid freeze-thaw cycles.